Champions Oncology (CSBR)
Provides oncology research services, patient-derived models, testing platforms, and data offerings for biopharma.
$5.15
At close+0.15 (+3.00%)
Something off on this page? Send us feedback.
Next report
Sep 14, 2026
in 11 days
EPS estimate
−$0.01
Revenue estimate
$15.0M
Fiscal quarter
Q1 FY27
EPSReportedEstimate
Dec '24Mar '25Jul '25Sep '25Dec '25Mar '26Jul '26Sep '26
Reported$0.05$0.31−$0.13−$0.03$0.02−$0.02$0.01Pending
Estimate$0.01−$0.01$0.06$0.01$0.08$0.09−$0.05−$0.01
Surprise+400.0%+3,200.0%−316.7%−400.0%−75.0%−122.2%+120.0%—
RevenueReportedEstimate
Dec '24Mar '25Jul '25Sep '25Dec '25Mar '26Jul '26Sep '26
Reported$13.5M$17.0M$12.4M$14.0M$15.0M$16.6M$13.8MPending
Estimate$13.1M$12.0M$14.7M$14.0M$16.4M$16.6M$12.9M$15.0M
Surprise+3.3%+41.8%−15.8%−0.3%−8.5%−0.3%+7.4%—
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Sep 2026 | −$0.01 | — | — |
| Jul 2026 | −$0.05 | $0.01 | +120.0% |
| Mar 2026 | $0.09 | −$0.02 | −122.2% |
| Dec 2025 | $0.08 | $0.02 | −75.0% |
| Sep 2025 | $0.01 | −$0.03 | −400.0% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Jul 2025 | |||
| Mar 2025 | |||
| Dec 2024 | |||
| Sep 2024 | |||
| Jul 2024 | |||
| Mar 2024 | |||
| Dec 2023 | |||
| Sep 2023 | |||
| Jul 2023 | |||
| Mar 2023 | |||
| Dec 2022 | |||
| Sep 2022 | |||
| Jul 2022 | |||
| Mar 2022 | |||
| Dec 2021 | |||
| Sep 2021 | |||
| Jul 2021 | |||
| Mar 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jul 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jul 2019 | |||
| Mar 2019 | |||
| Dec 2018 | |||
| Sep 2018 | |||
| Jul 2018 | |||
| Mar 2018 | |||
| Dec 2017 | |||
| Sep 2017 | |||
| Jul 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Sep 2016 | |||
| Jul 2016 | |||
| Mar 2016 | |||
| Dec 2015 | |||
| Sep 2015 | |||
| Jul 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | −$0.01 | — | — | $15.0M | — | — | — |
| Jul 27, 2026 | −$0.05 | $0.01 | +120.0% | $12.9M | $13.8M | +7.4% | −8.8% |
| Mar 12, 2026 | $0.09 | −$0.02 | −122.2% | $16.6M | $16.6M | −0.3% | +6.3% |
| Dec 15, 2025 | $0.08 | $0.02 | −75.0% | $16.4M | $15.0M | −8.5% | −13.7% |
| Sep 15, 2025 | $0.01 | −$0.03 | −400.0% | $14.0M | $14.0M | −0.3% | −16.0% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||||||
| Jul 23, 2025 | |||||||
| Mar 11, 2025 | |||||||
| Dec 11, 2024 | |||||||
| Sep 11, 2024 | |||||||
| Jul 18, 2024 | |||||||
| Mar 12, 2024 | |||||||
| Dec 12, 2023 | |||||||
| Sep 13, 2023 | |||||||
| Jul 24, 2023 | |||||||
| Mar 15, 2023 | |||||||
| Dec 13, 2022 | |||||||
| Sep 8, 2022 | |||||||
| Jul 21, 2022 | |||||||
| Mar 15, 2022 | |||||||
| Dec 13, 2021 | |||||||
| Sep 13, 2021 | |||||||
| Jul 22, 2021 | |||||||
| Mar 11, 2021 | |||||||
| Dec 14, 2020 | |||||||
| Sep 14, 2020 | |||||||
| Jul 27, 2020 | |||||||
| Mar 12, 2020 | |||||||
| Dec 16, 2019 | |||||||
| Sep 16, 2019 | |||||||
| Jul 15, 2019 | |||||||
| Mar 18, 2019 | |||||||
| Dec 17, 2018 | |||||||
| Sep 13, 2018 | |||||||
| Jul 26, 2018 | |||||||
| Mar 15, 2018 | |||||||
| Dec 7, 2017 | |||||||
| Sep 14, 2017 | |||||||
| Jul 27, 2017 | |||||||
| Mar 16, 2017 | |||||||
| Nov 29, 2016 | |||||||
| Sep 9, 2016 | |||||||
| Jul 28, 2016 | |||||||
| Mar 15, 2016 | |||||||
| Dec 14, 2015 | |||||||
| Sep 10, 2015 | |||||||
| Jul 28, 2015 | |||||||